Logo image of MTD

METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis

NYSE:MTD - New York Stock Exchange, Inc. - US5926881054 - Common Stock

1324.48  +29.05 (+2.24%)

After market: 1324.48 0 (0%)

Fundamental Rating

5

Overall MTD gets a fundamental rating of 5 out of 10. We evaluated MTD against 56 industry peers in the Life Sciences Tools & Services industry. MTD scores excellent on profitability, but there are some minor concerns on its financial health. MTD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

MTD had positive earnings in the past year.
In the past year MTD had a positive cash flow from operations.
Each year in the past 5 years MTD has been profitable.
In the past 5 years MTD always reported a positive cash flow from operatings.
MTD Yearly Net Income VS EBIT VS OCF VS FCFMTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of MTD (23.97%) is better than 100.00% of its industry peers.
The Return On Invested Capital of MTD (40.43%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MTD is significantly above the industry average of 9.93%.
The 3 year average ROIC (39.06%) for MTD is below the current ROIC(40.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 23.97%
ROE N/A
ROIC 40.43%
ROA(3y)23.87%
ROA(5y)22.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.06%
ROIC(5y)35.9%
MTD Yearly ROA, ROE, ROICMTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K

1.3 Margins

MTD's Profit Margin of 21.15% is amongst the best of the industry. MTD outperforms 98.21% of its industry peers.
MTD's Profit Margin has improved in the last couple of years.
MTD has a better Operating Margin (28.24%) than 98.21% of its industry peers.
MTD's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 59.48%, MTD belongs to the top of the industry, outperforming 82.14% of the companies in the same industry.
MTD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.24%
PM (TTM) 21.15%
GM 59.48%
OM growth 3Y3.43%
OM growth 5Y4%
PM growth 3Y2.15%
PM growth 5Y3.58%
GM growth 3Y0.45%
GM growth 5Y0.61%
MTD Yearly Profit, Operating, Gross MarginsMTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MTD is creating value.
The number of shares outstanding for MTD has been reduced compared to 1 year ago.
MTD has less shares outstanding than it did 5 years ago.
MTD has a worse debt/assets ratio than last year.
MTD Yearly Shares OutstandingMTD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
MTD Yearly Total Debt VS Total AssetsMTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 10.34 indicates that MTD is not in any danger for bankruptcy at the moment.
MTD has a better Altman-Z score (10.34) than 94.64% of its industry peers.
The Debt to FCF ratio of MTD is 2.34, which is a good value as it means it would take MTD, 2.34 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.34, MTD belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.34
Altman-Z 10.34
ROIC/WACC3.87
WACC10.44%
MTD Yearly LT Debt VS Equity VS FCFMTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.01 indicates that MTD should not have too much problems paying its short term obligations.
MTD's Current ratio of 1.01 is on the low side compared to the rest of the industry. MTD is outperformed by 85.71% of its industry peers.
A Quick Ratio of 0.69 indicates that MTD may have some problems paying its short term obligations.
The Quick ratio of MTD (0.69) is worse than 94.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.69
MTD Yearly Current Assets VS Current LiabilitesMTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

MTD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.45%.
MTD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.34% yearly.
Looking at the last year, MTD shows a decrease in Revenue. The Revenue has decreased by -3.80% in the last year.
Measured over the past years, MTD shows a small growth in Revenue. The Revenue has been growing by 5.23% on average per year.
EPS 1Y (TTM)-6.45%
EPS 3Y14.2%
EPS 5Y13.34%
EPS Q2Q%4.18%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y7.08%
Revenue growth 5Y5.23%
Sales Q2Q%1.28%

3.2 Future

MTD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.67% yearly.
MTD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.85% yearly.
EPS Next Y7.62%
EPS Next 2Y5.96%
EPS Next 3Y7.88%
EPS Next 5Y9.67%
Revenue Next Year0.81%
Revenue Next 2Y1.83%
Revenue Next 3Y3.11%
Revenue Next 5Y3.85%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MTD Yearly Revenue VS EstimatesMTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
MTD Yearly EPS VS EstimatesMTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20 40 60

4

4. Valuation

4.1 Price/Earnings Ratio

MTD is valuated quite expensively with a Price/Earnings ratio of 34.72.
Based on the Price/Earnings ratio, MTD is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.29. MTD is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 30.98, MTD can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MTD indicates a somewhat cheap valuation: MTD is cheaper than 69.64% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.44. MTD is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 34.72
Fwd PE 30.98
MTD Price Earnings VS Forward Price EarningsMTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTD is valued a bit cheaper than 76.79% of the companies in the same industry.
80.36% of the companies in the same industry are more expensive than MTD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.45
EV/EBITDA 24.75
MTD Per share dataMTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MTD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.56
PEG (5Y)2.6
EPS Next 2Y5.96%
EPS Next 3Y7.88%

0

5. Dividend

5.1 Amount

No dividends for MTD!.
Industry RankSector Rank
Dividend Yield N/A

METTLER-TOLEDO INTERNATIONAL

NYSE:MTD (1/21/2025, 8:15:48 PM)

After market: 1324.48 0 (0%)

1324.48

+29.05 (+2.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners98.96%
Inst Owner Change0.33%
Ins Owners0.4%
Ins Owner Change1.37%
Market Cap27.95B
Analysts54.29
Price Target1382.11 (4.35%)
Short Float %1.57%
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.39%
Min EPS beat(2)1.02%
Max EPS beat(2)5.75%
EPS beat(4)3
Avg EPS beat(4)3.51%
Min EPS beat(4)-7.89%
Max EPS beat(4)15.16%
EPS beat(8)6
Avg EPS beat(8)2.2%
EPS beat(12)10
Avg EPS beat(12)3.1%
EPS beat(16)14
Avg EPS beat(16)4.27%
Revenue beat(2)2
Avg Revenue beat(2)0.46%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.89%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-3.41%
Max Revenue beat(4)4.21%
Revenue beat(8)5
Avg Revenue beat(8)-0.14%
Revenue beat(12)9
Avg Revenue beat(12)0.31%
Revenue beat(16)13
Avg Revenue beat(16)1.12%
PT rev (1m)0.46%
PT rev (3m)-3.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.14%
EPS NY rev (1m)0%
EPS NY rev (3m)0.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 34.72
Fwd PE 30.98
P/S 7.43
P/FCF 31.45
P/OCF 28.41
P/B N/A
P/tB N/A
EV/EBITDA 24.75
EPS(TTM)38.15
EY2.88%
EPS(NY)42.75
Fwd EY3.23%
FCF(TTM)42.11
FCFY3.18%
OCF(TTM)46.62
OCFY3.52%
SpS178.3
BVpS-7.32
TBVpS-51.62
PEG (NY)4.56
PEG (5Y)2.6
Profitability
Industry RankSector Rank
ROA 23.97%
ROE N/A
ROCE 49.76%
ROIC 40.43%
ROICexc 41.83%
ROICexgc 76.5%
OM 28.24%
PM (TTM) 21.15%
GM 59.48%
FCFM 23.62%
ROA(3y)23.87%
ROA(5y)22.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.06%
ROIC(5y)35.9%
ROICexc(3y)40.66%
ROICexc(5y)37.86%
ROICexgc(3y)73.64%
ROICexgc(5y)66.69%
ROCE(3y)48.08%
ROCE(5y)44.19%
ROICexcg growth 3Y10.23%
ROICexcg growth 5Y5.45%
ROICexc growth 3Y6.66%
ROICexc growth 5Y4.94%
OM growth 3Y3.43%
OM growth 5Y4%
PM growth 3Y2.15%
PM growth 5Y3.58%
GM growth 3Y0.45%
GM growth 5Y0.61%
F-Score6
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.34
Debt/EBITDA 1.6
Cap/Depr 77.26%
Cap/Sales 2.53%
Interest Coverage 250
Cash Conversion 82.98%
Profit Quality 111.68%
Current Ratio 1.01
Quick Ratio 0.69
Altman-Z 10.34
F-Score6
WACC10.44%
ROIC/WACC3.87
Cap/Depr(3y)97.91%
Cap/Depr(5y)99.43%
Cap/Sales(3y)2.92%
Cap/Sales(5y)3%
Profit Quality(3y)99.29%
Profit Quality(5y)98.59%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.45%
EPS 3Y14.2%
EPS 5Y13.34%
EPS Q2Q%4.18%
EPS Next Y7.62%
EPS Next 2Y5.96%
EPS Next 3Y7.88%
EPS Next 5Y9.67%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y7.08%
Revenue growth 5Y5.23%
Sales Q2Q%1.28%
Revenue Next Year0.81%
Revenue Next 2Y1.83%
Revenue Next 3Y3.11%
Revenue Next 5Y3.85%
EBIT growth 1Y-8.61%
EBIT growth 3Y10.75%
EBIT growth 5Y9.44%
EBIT Next Year8.53%
EBIT Next 3Y6.31%
EBIT Next 5Y6.93%
FCF growth 1Y32.72%
FCF growth 3Y10.83%
FCF growth 5Y15.3%
OCF growth 1Y23.49%
OCF growth 3Y10.05%
OCF growth 5Y11.32%